Thomas Trimarchi, Ph.D.

Thomas Trimarchi, Ph.D.

President and Chief Financial OfficeratBridgeBio Pharma· In proxies 2024–2025

Pay in FY2024BridgeBio Pharma stock -32.0% the same year

Thomas Trimarchi, Ph.D. was paid $6.5M in FY2024 (Dec). BridgeBio Pharma stock fell 32.0% that year.

Pay$100 in the stock at the end of FY23 → $68
Pay is from the Summary Compensation Table of each BridgeBio Pharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BridgeBio PharmaPublic company · 2 yr
    • President and Chief Financial Officer2024 – Present · 2 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?